IFP Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.4K Buy
1,367
+89
+7% +$2.13K ﹤0.01% 2543
2025
Q4
$34.1K Buy
1,278
+173
+16% +$4.13K ﹤0.01% 2411
2025
Q3
$23.6K Sell
1,105
-2,321
-68% -$54.9K ﹤0.01% 2507
2025
Q2
$73.9K Buy
3,426
+14
+0.4% +$260 ﹤0.01% 1830
2025
Q1
$56.7K Sell
3,412
-646
-16% -$11.7K ﹤0.01% 1843
2024
Q4
$74.5K Buy
4,058
+498
+14% +$8.04K ﹤0.01% 1624
2024
Q3
$54.7K Buy
3,560
+879
+33% +$14.7K ﹤0.01% 1693
2024
Q2
$43.6K Buy
2,681
+1,231
+85% +$19.9K ﹤0.01% 1739
2024
Q1
$26.8K Buy
+1,450
New +$35.9K ﹤0.01% 1846
2023
Q2
Sell
-1,500
Closed -$27.5K 3441
2023
Q1
$27.5K Sell
1,500
-500
-25% -$9.52K ﹤0.01% 1876
2022
Q4
$37K Sell
2,000
-27
-1% -$422 ﹤0.01% 2434
2022
Q3
$38K Buy
2,027
+1,500
+285% +$24.3K ﹤0.01% 2570
2022
Q2
$10K Hold
527
﹤0.01% 3372
2022
Q1
$10K Buy
+527
New +$12.8K ﹤0.01% 3372
2021
Q3
Sell
-152
Closed -$4K 3366
2021
Q2
$4K Sell
152
-148
-49% -$3.34K ﹤0.01% 2523
2021
Q1
$8K Buy
300
+100
+50% +$4.4K ﹤0.01% 2203
2020
Q4
$11K Buy
+200
New +$9.93K ﹤0.01% 2022
2020
Q3
Sell
-22
Closed -$950 2830
2020
Q2
$1K Buy
+22
New +$1.06K ﹤0.01% 2491
2020
Q1
Hold
0
2753
2019
Q4
Hold
0
2825
2019
Q3
Hold
0
3066
2019
Q1
Sell
-1,186
Closed -$19K 2348
2018
Q4
$19K Buy
1,186
+750
+172% +$14.6K ﹤0.01% 2156
2018
Q3
$9K Buy
436
+118
+37% +$1.86K ﹤0.01% 2888
2018
Q2
$5K Sell
318
-518
-62% -$9.24K ﹤0.01% 3221
2018
Q1
$25K Hold
836
﹤0.01% 2236
2017
Q4
$25K Sell
836
-1,682
-67% -$53.8K ﹤0.01% 2265
2017
Q3
$95K Buy
2,518
+475
+23% +$15.5K ﹤0.01% 1588
2017
Q2
$57K Sell
2,043
-975
-32% -$29.1K ﹤0.01% 1877
2017
Q1
$104K Sell
3,018
-3,091
-51% -$109K ﹤0.01% 1470
2016
Q4
$176K Sell
6,109
-2,688
-31% -$71.1K 0.01% 1116
2016
Q3
$280K Buy
8,797
+2,350
+36% +$79.7K 0.01% 842
2016
Q2
$209K Buy
+6,447
New +$216K 0.01% 946
2016
Q1
Sell
-4,249
Closed -$151K 2343
2015
Q4
$151K Buy
+4,249
New +$150K 0.01% 965

Other funds holding ACAD